Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminodi(ethyloxy)ethylaminocarbonylbenzenesulfonamide is a synthetic small molecule belonging to the benzenesulfonamide class, characterized by a sulfonamide group attached to a benzene ring and an ethyloxyethylamine side chain. Its molecular formula is C13H21N3O5S, with a molecular weight of approximately 331.39 g/mol[1][2][3]. The compound has been studied primarily as an experimental agent and is not approved for clinical use. Benzenesulfonamides are known for their antibacterial activity, typically acting by inhibiting bacterial folic acid synthesis—a mechanism that disrupts nucleic acid production in bacteria[3][5]. The presence of the aminoethoxy moiety may also allow for additional biological interactions, potentially expanding its pharmacological profile beyond antibacterial effects. However, there are no specific indications or approved uses reported for this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aminodi(ethyloxy)ethylaminocarbonylbenzenesulfonamide.